BACKGROUND: High circulating levels of homocysteine are a risk factor for arterial and venous thrombosis. This association has been established in numerous case-control studies. In some of these studies, patients were treated with anticoagulants at the time of venapuncture. It is not clear whether homocysteine concentrations are influenced by anticoagulants. If anticoagulation does, indeed, have an effect on homocysteine levels, it might underestimate or overestimate the possible association of homocysteine levels and vascular disease. METHODS: In this study we used two different groups to investigate the effect of coumarin derivatives on homocysteine concentrations. Homocysteine levels were measured in 40 patients who were on the waiting l...
The correlation between homocysteine and vascular disease has been assessed in several clinical stud...
Item does not contain fulltextBACKGROUND: Suboptimal platelet inhibition with antiplatelet treatment...
Although hyperhomocysteinemia is an established risk factor for venous thromboembolism there is no c...
Contains fulltext : 49651.pdf (publisher's version ) (Closed access)BACKGROUND: Hi...
Homocysteine has been implicated in promoting atherosclerotic and thrombotic vascular disease. Durin...
Background: Waiting temperature before centrifugation and anticoagulants used, markedly effect total...
Summary: A high plasma homocysteine concentration is as-sociated with premature vascular disease and...
Background and Purpose - Epidemiological and laboratory studies suggest that increasing concentratio...
Published online before print November 29, 2004Background and Purpose— Epidemiological and laborator...
Background: Plasma homocysteine is an independent non-traditional risk factor for atherosclerotic ca...
Homocysteine is a sulphydryl-containing aminoacid derived from demethylation of methionine. Nutritio...
Jutta Dierkes, Claus Luley, Sabine WestphalInstitute of Clinical Chemistry and Biochemistry, Univers...
Context. - Elevated plasma homocysteine is a known risk factor for atherosclerotic vascular disease,...
Elevated homocysteine levels are associated with an increased cardiovascular disease (CVD) risk, but...
International audienceMild or moderate hyperhomocysteinemia as a risk factor for venous thrombosis i...
The correlation between homocysteine and vascular disease has been assessed in several clinical stud...
Item does not contain fulltextBACKGROUND: Suboptimal platelet inhibition with antiplatelet treatment...
Although hyperhomocysteinemia is an established risk factor for venous thromboembolism there is no c...
Contains fulltext : 49651.pdf (publisher's version ) (Closed access)BACKGROUND: Hi...
Homocysteine has been implicated in promoting atherosclerotic and thrombotic vascular disease. Durin...
Background: Waiting temperature before centrifugation and anticoagulants used, markedly effect total...
Summary: A high plasma homocysteine concentration is as-sociated with premature vascular disease and...
Background and Purpose - Epidemiological and laboratory studies suggest that increasing concentratio...
Published online before print November 29, 2004Background and Purpose— Epidemiological and laborator...
Background: Plasma homocysteine is an independent non-traditional risk factor for atherosclerotic ca...
Homocysteine is a sulphydryl-containing aminoacid derived from demethylation of methionine. Nutritio...
Jutta Dierkes, Claus Luley, Sabine WestphalInstitute of Clinical Chemistry and Biochemistry, Univers...
Context. - Elevated plasma homocysteine is a known risk factor for atherosclerotic vascular disease,...
Elevated homocysteine levels are associated with an increased cardiovascular disease (CVD) risk, but...
International audienceMild or moderate hyperhomocysteinemia as a risk factor for venous thrombosis i...
The correlation between homocysteine and vascular disease has been assessed in several clinical stud...
Item does not contain fulltextBACKGROUND: Suboptimal platelet inhibition with antiplatelet treatment...
Although hyperhomocysteinemia is an established risk factor for venous thromboembolism there is no c...